Nanobiotix S.A. (LON:0QAV)
4.140
-0.155 (-3.60%)
At close: Jul 7, 2025
Nanobiotix Employees
Nanobiotix had 108 employees as of December 31, 2024. The number of employees increased by 6 or 5.88% compared to the previous year.
Employees
108
Change (1Y)
6
Growth (1Y)
5.88%
Revenue / Employee
-55.05K GBP
Profits / Employee
-521.70K GBP
Market Cap
189.34M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Oxford Nanopore Technologies | 1,382 |
Nanobiotix News
- 6 weeks ago - NANOBIOTIX to Participate in the Jefferies Global Healthcare Investor Conference - GlobeNewsWire
- 7 weeks ago - Nanobiotix Provides First Quarter 2025 Operational and Financial Update - GlobeNewsWire
- 2 months ago - Nanobiotix to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ - GlobeNewsWire
- 2 months ago - Nanobiotix Announces Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in ... - GuruFocus
- 2 months ago - Nanobiotix Announces Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Pancreatic Cancer - GlobeNewsWire
- 2 months ago - Nanobiotix Announces Presentation of Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Pancreatic Cancer Followed by a Conference Call - GlobeNewsWire
- 3 months ago - Nanobiotix S.A. (NBTX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Nanobiotix GAAP EPS of -€1.44 - Seeking Alpha